Masaharu Hirata

600 total citations
35 papers, 514 citations indexed

About

Masaharu Hirata is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Masaharu Hirata has authored 35 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Biochemistry and 10 papers in Pharmacology. Recurrent topics in Masaharu Hirata's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Masaharu Hirata is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Masaharu Hirata collaborates with scholars based in Japan, Sweden and United States. Masaharu Hirata's co-authors include Osamu Hayaishi, Kenji Kawada, Tadahiko Tsushima, Osamu Shiratori, Kouji Ohno, Masanobu Tokushige, Sten Orrenius, ATSUKO NODA, Toshio Yoshizaki and Björn Lindeke and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Colloid and Interface Science.

In The Last Decade

Masaharu Hirata

34 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaharu Hirata Japan 13 287 109 80 63 58 35 514
Toshitaka Koga Japan 12 273 1.0× 128 1.2× 43 0.5× 16 0.3× 38 0.7× 42 552
Rubén Alvarez‐Sánchez Switzerland 15 294 1.0× 94 0.9× 74 0.9× 38 0.6× 61 1.1× 24 728
J. P. Beaucourt France 15 152 0.5× 278 2.6× 47 0.6× 46 0.7× 22 0.4× 53 483
Shigeyasu Ichihara Japan 14 257 0.9× 69 0.6× 15 0.2× 94 1.5× 65 1.1× 30 512
H L Segal United States 12 471 1.6× 68 0.6× 29 0.4× 141 2.2× 27 0.5× 16 807
William Hageman United States 13 212 0.7× 234 2.1× 28 0.3× 17 0.3× 74 1.3× 33 610
A. A. PATCHETT United States 13 339 1.2× 237 2.2× 24 0.3× 25 0.4× 38 0.7× 25 664
J. Y. GAUTHIER Canada 11 240 0.8× 218 2.0× 18 0.2× 36 0.6× 62 1.1× 20 582
Kiyoshi Iwamoto Japan 13 296 1.0× 124 1.1× 77 1.0× 29 0.5× 14 0.2× 25 482
Steven G. Wood United States 15 284 1.0× 153 1.4× 14 0.2× 20 0.3× 31 0.5× 23 562

Countries citing papers authored by Masaharu Hirata

Since Specialization
Citations

This map shows the geographic impact of Masaharu Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaharu Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaharu Hirata more than expected).

Fields of papers citing papers by Masaharu Hirata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaharu Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaharu Hirata. The network helps show where Masaharu Hirata may publish in the future.

Co-authorship network of co-authors of Masaharu Hirata

This figure shows the co-authorship network connecting the top 25 collaborators of Masaharu Hirata. A scholar is included among the top collaborators of Masaharu Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaharu Hirata. Masaharu Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirata, Masaharu, et al.. (1995). Induction of Cytochrome P450 3A (CYP 3A) by E 5110, a Non-steroidal Anti-inflammatory Agent (NSAID), and Typical CYP 3A Inducers in Primary Cultures of Dog Hepatocytes.. Biological and Pharmaceutical Bulletin. 18(8). 1142–1144. 11 indexed citations
2.
Ohno, Kouji & Masaharu Hirata. (1993). Characterization of the transport system of prostaglandin A2 in L-1210 murine leukemia cells. Biochemical Pharmacology. 46(4). 661–670. 12 indexed citations
3.
Seo, Shujiro, et al.. (1993). Effect of sterol biosynthesis inhibitor, SSF-109, on cholesterol synthesis in isolated rat hepatocytes. Steroids. 58(2). 74–78. 8 indexed citations
4.
Hirata, Masaharu. (1992). Glutathione, a regulator of cell functions.. Drug Metabolism and Pharmacokinetics. 7(1). 113–131. 1 indexed citations
5.
Yoshizaki, Toshio, et al.. (1991). Plasma biochemistry values of young beagle dogs.. The Journal of Toxicological Sciences. 16(2). 49–59. 20 indexed citations
6.
Ohno, Kouji, Masafumi Fujimoto, & Masaharu Hirata. (1991). Protective effect of prostaglandin A2 against menadione-induced cell injury in cultured porcine aorta endothelial cells. Chemico-Biological Interactions. 78(1). 67–75. 9 indexed citations
7.
Takahashi, Shirō, et al.. (1989). Metabolism of a thromboxane A2 antagonist in isolated rat hepatocytes. Journal of Mass Spectrometry. 18(12). 1057–1062. 3 indexed citations
8.
Harada, Hiroshi, et al.. (1989). Chemical Structure and Toxicity of Diuretics in Isolated Hepatocytes. Pharmacology & Toxicology. 65(1). 21–24. 1 indexed citations
9.
Hirata, Masaharu, et al.. (1989). Stereoselective glutathione conjugation of a uricosuric diuretic. Chemico-Biological Interactions. 72(1-2). 209–214. 4 indexed citations
10.
Hirata, Masaharu, et al.. (1988). Effect of .BETA.-lactam antibiotics on hepatocellular glutathione levels in vitro and in vivo.. The Journal of Toxicological Sciences. 13(1). 41–47. 2 indexed citations
11.
Hata, Yoshiteru, et al.. (1987). Aziridine biotransformation by microsomes and lethality to hepatocytes isolated from rat. Chemico-Biological Interactions. 63(2). 171–184. 15 indexed citations
12.
Hirata, Masaharu, et al.. (1986). Potentiation of antitumor activity of 1-phthalidyl 5-fluorouracil by acetazolamide. Cancer Chemotherapy and Pharmacology. 16(1). 55–7. 1 indexed citations
13.
NODA, ATSUKO, et al.. (1985). Spin trapping of a free radical intermediate formed during microsomal metabolism of hydrazine. Biochemical and Biophysical Research Communications. 133(3). 1086–1091. 28 indexed citations
14.
NODA, ATSUKO, et al.. (1982). Studies of isoniazid metabolism in isolated rat hepatocytes by mass fragmentography. Journal of Chromatography B Biomedical Sciences and Applications. 230(2). 345–352. 14 indexed citations
15.
Hirata, Masaharu, et al.. (1981). Distribution study of a synthetic ACTH analogue in rat tissue. European Journal of Endocrinology. 96(4). 464–469. 3 indexed citations
16.
Hirata, Masaharu, et al.. (1981). Metabolism of isoniazid and free hydrazine formation in isolated rat hepatocytes.. Journal of Pharmacobio-Dynamics. 4(2). 145–147. 7 indexed citations
17.
Hirata, Masaharu, Björn Lindeke, & Sten Orrenius. (1979). Cytochrome P450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners. Biochemical Pharmacology. 28(4). 479–484. 16 indexed citations
18.
Hirata, Masaharu, et al.. (1978). Rectal absorption of gly1-.ALPHA.1-18 adrenocorticotropin amide.. Chemical and Pharmaceutical Bulletin. 26(4). 1061–1065. 4 indexed citations
19.
Hirata, Masaharu & Osamu Hayaishi. (1967). Adenyl cyclase of Brevibacterium liquefaciens. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 149(1). 1–11. 86 indexed citations
20.
Hirata, Masaharu & Osamu Hayaishi. (1965). Pyruvate dependent adenyl cyclase activity of Brevibacterium, liquefaciens. Biochemical and Biophysical Research Communications. 21(4). 361–365. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshitaka Koga Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by J. P. Beaucourt Breakdown of academic impact, for papers by Shigeyasu Ichihara Breakdown of academic impact, for papers by H L Segal Breakdown of academic impact, for papers by William Hageman Breakdown of academic impact, for papers by A. A. PATCHETT Breakdown of academic impact, for papers by J. Y. GAUTHIER Breakdown of academic impact, for papers by Kiyoshi Iwamoto Breakdown of academic impact, for papers by Steven G. Wood
Rankless by CCL
2026